| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 14 |
| 1 | SILDENAFIL CITRATE | 14 |
| 2 | TREPROSTINIL | 12 |
| 3 | SILDENAFIL | 11 |
| 4 | FUROSEMIDE | 9 |
| 5 | AMLODIPINE | 8 |
| 6 | BEVACIZUMAB | 8 |
| 7 | BOSENTAN | 8 |
| 8 | MACITENTAN | 8 |
| 9 | SILDENAFIL POWDER, | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZETHONIUM CHLORIDE 0.13% | 1 | 0.0152 |
| 1 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 2 | BEVACIZUMAB-AWWB | 3 | 0.0006 |
| 3 | FERUMOXYTOL | 1 | 0.0005 |
| 4 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 6 | TRANEXAMIC ACID | 3 | 0.0003 |
| 7 | ZIPRASIDONE | 1 | 0.0003 |
| 8 | FOSINOPRIL | 1 | 0.0002 |
| 9 | SELEXIPAG | 6 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Antifibrinolytic Agent [EPC] | 4 | 0.0004 |
| 2 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 6 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 14 | 0.0001 |
| 6 | Endothelin Receptor Antagonist [EPC] | 20 | 0.0001 |
| 7 | Prostacycline Vasodilator [EPC] | 13 | 0.0001 |
| 8 | Cardiac Glycoside [EPC] | 6 | 0.0001 |
| 9 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |